Reach Neuro
Giving control and independence back to people with stroke.
Pittsburgh, United States · Founded 2021 · $880K raised
- Headquarters
- Pittsburgh, Pennsylvania
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- reachneuro.com
- Total Funding
- $880K
- Last Round
- $200K SeedJun 2025
- Rounds
- 2
About
Reach Neuro is a neurotechnology startup developing spinal cord stimulation devices to restore shoulder, arm, and hand movement for people with chronic stroke and other neurological disorders. The company's Avantis platform — which received FDA Breakthrough Device designation in 2023 — uses implanted electrode arrays and a pulse generator to deliver personalized stimulation protocols that re-awaken the nervous system and directly restore a patient's ability to control their own movement. Co-founded by researchers from Brown University and the University of Pittsburgh, Reach Neuro is backed by SOSV and has demonstrated first-in-human results published in Nature Medicine.
Summary
Reach Neuro is a company based in Pittsburgh, United States, founded in 2021. It has raised $880K in total across 2 rounds, most recently a $200K Seed round in Jun 2025. Investors include Angel Investor Forum, IndieBio and SOSV.
Tech & App Stack
1 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jun 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
